![]() GSK 1702934A structure
|
Common Name | GSK 1702934A | ||
---|---|---|---|---|
CAS Number | 924377-85-5 | Molecular Weight | 395.52 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H25N3O2S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of GSK 1702934AGSK1702934A is a selective TRPC3 agonist. GSK1702934A modulates cardiac contractility and f arrhythmogenesis by activation of TRPC3[1][2]. |
Name | GSK1702934A |
---|
Description | GSK1702934A is a selective TRPC3 agonist. GSK1702934A modulates cardiac contractility and f arrhythmogenesis by activation of TRPC3[1][2]. |
---|---|
Related Catalog | |
Target |
TRPC3 |
In Vitro | GSK1702934A is able to induce TRPC3/6-currents in HEK293 cells transduced with recombinant human TRPC3/6 with an EC50 of 0.08 mM and 0.44 mM, respectively[1]. GSK1702934A induces a transient, non-selective conductance and prolonged action potentials in TRPC3-overexpressing myocytes but not in wild-type myocytes[2]. GSK1702934A substantially promotes NCX currents in TRPC3-overexpressing myocytes[2]. |
References |
Molecular Formula | C22H25N3O2S |
---|---|
Molecular Weight | 395.52 |